Advanz Pharma Drug Patent Portfolio
Advanz Pharma owns 3 orange book drugs protected by 6 US patents Given below is the list of Advanz Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6740341 | Taste masking rapid release coating system | 24 Nov, 2019 | Expired |
| US6024981 | Rapidly dissolving robust dosage form | 09 Apr, 2018 | Expired |
| US6221392 | Rapidly dissolving robust dosage form | 09 Apr, 2018 | Expired |
| US6149940 | Tablet with controlled release of alfuzosine chlorhydrate | 22 Feb, 2018 | Expired |
| US6149940 | Tablet with controlled release of alfuzosine chlorhydrate | 22 Aug, 2017 | Expired |
| US5932622 | Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid | 03 Aug, 2016 | Expired |
Advanz Pharma's Family Patents
Advanz Pharma Drug List
Given below is the complete list of Advanz Pharma's drugs and the patents protecting them.
1. Orapred Odt
Orapred Odt is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6740341 | Taste masking rapid release coating system |
24 Nov, 2019
(5 years ago)
| Expired |
| US6024981 | Rapidly dissolving robust dosage form |
09 Apr, 2018
(6 years ago)
| Expired |
| US6221392 | Rapidly dissolving robust dosage form |
09 Apr, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Orapred Odt's drug page
2. Panretin
Panretin is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5932622 | Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid |
03 Aug, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Panretin's drug page
3. Uroxatral
Uroxatral is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6149940
(Pediatric)
| Tablet with controlled release of alfuzosine chlorhydrate |
22 Feb, 2018
(6 years ago)
| Expired |
| US6149940 | Tablet with controlled release of alfuzosine chlorhydrate |
22 Aug, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Uroxatral's drug page